RACHEL CAMERON: Open Payments
NPI 1760779557 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$794 in 39 payments from 19 companies in 2025. Trend: 2023 $1,530 · 2024 $1,381 · 2025 $794
Food & beverage: $794
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 5 | $104 |
| Almatica Pharma LLC | 3 | $73 |
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| HARMONY BIOSCIENCES LLC | 2 | $66 |
| Corcept Therapeutics | 3 | $64 |
| Antares Pharma, Inc. | 3 | $58 |
| E.R. Squibb & Sons, L.L.C. | 2 | $43 |
| Paratek Pharmaceuticals, Inc. | 2 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
Products named: Auvelity, LOREEV XR, WAKIX, Korlym, XYOSTED, COBENFY, NUZYRA, XIFAXAN.
Industry payments across OK — which companies pay providers there.
